# S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer

> **NCT00003018** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 54 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** dipyridamole
- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **DRUG:** mitomycin C

## Key facts

- **NCT ID:** NCT00003018
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-09
- **Primary completion:** 2002-01
- **Final completion:** 2007-01
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2013-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003018, "S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00003018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*